Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioni
The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal
| Condition(s) | Migraine, Migraine Disease |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal phase of the migraine attack; pharmacological therapy; and detoxification treatment in patients with migraine associated with medication overuse headache. |
| Who can participate | Inclusion Criteria: * Written informed consent. * Patients aged between 18 and 65 years. * Diagnosis of migraine according to the International Classification of Headache Disorders (ICHD-3) criteria. * Patients with a history of migraine for at least one year, to ensure the stability of the condition. * Stability of ongoing treatment for at least 3 months at baseline. * Understanding of the Italian language. Exclusion Criteria: * Severe medical or psychiatric conditions (depression, schizophrenia, psychosis) documented by specific previous diagnoses. * A history of alcohol or drug abuse. * Primary sensory deficits. |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Lead sponsor | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta |
| Locations | Milan, Italy |
| Start date | 2025-09-01 |
| NCT ID | NCT07233941 |
| Official listing | https://clinicaltrials.gov/study/NCT07233941 |